• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Tea's value as a cancer therapy is steeped in uncertainty.

作者信息

Eisenstein Michael

出版信息

Nature. 2019 Feb;566(7742):S6-S7. doi: 10.1038/d41586-019-00397-2.

DOI:10.1038/d41586-019-00397-2
PMID:30728516
Abstract
摘要

相似文献

1
Tea's value as a cancer therapy is steeped in uncertainty.茶作为一种癌症治疗方法的价值充满了不确定性。
Nature. 2019 Feb;566(7742):S6-S7. doi: 10.1038/d41586-019-00397-2.
2
Clinical development plan: tea extracts. Green tea polyphenols. Epigallocatechin gallate.临床开发计划：茶提取物。绿茶多酚。表没食子儿茶素没食子酸酯。
J Cell Biochem Suppl. 1996;26:236-57.
3
Green tea: prevention and treatment of cancer by nutraceuticals.绿茶：营养保健品对癌症的预防与治疗
Lancet. 2004;364(9439):1021-2. doi: 10.1016/S0140-6736(04)17076-1.
4
The science of tea's mood-altering magic.茶改变情绪的神奇科学。
Nature. 2019 Feb;566(7742):S8-S9. doi: 10.1038/d41586-019-00398-1.
5
[Anti-cancer properties epigallocatechin-gallate contained in green tea].[绿茶中表没食子儿茶素没食子酸酯的抗癌特性]
Postepy Hig Med Dosw (Online). 2013 Jan 16;67:26-34. doi: 10.5604/17322693.1029528.
6
Cancer prevention by tea: animal studies, molecular mechanisms and human relevance.茶对癌症的预防作用：动物研究、分子机制及与人类的相关性
Nat Rev Cancer. 2009 Jun;9(6):429-39. doi: 10.1038/nrc2641.
7
Green tea and its catechins inhibit breast cancer xenografts.绿茶及其儿茶素可抑制乳腺癌异种移植瘤。
Nutr Cancer. 2001;40(2):149-56. doi: 10.1207/S15327914NC402_11.
8
Epigallocatechin 3-gallate and green tea catechins: United they work, divided they fail.表没食子儿茶素没食子酸酯与绿茶儿茶素：合则起效，分则失效。
Cancer Prev Res (Phila). 2009 Jun;2(6):514-7. doi: 10.1158/1940-6207.CAPR-09-0083. Epub 2009 May 26.
9
Efficacy of tea catechin-rich beverages to reduce abdominal adiposity and metabolic syndrome risks in obese and overweight subjects: a pooled analysis of 6 human trials.茶儿茶素丰富的饮料对肥胖和超重人群减少腹部肥胖和代谢综合征风险的功效：6 个人类试验的汇总分析。
Nutr Res. 2018 Jul;55:1-10. doi: 10.1016/j.nutres.2018.03.012. Epub 2018 Mar 23.
10
A minireview of effects of green tea on energy expenditure.绿茶对能量消耗影响的小综述。
Crit Rev Food Sci Nutr. 2017 Jan 22;57(2):254-258. doi: 10.1080/10408398.2014.986672.

引用本文的文献

1
Association between green tea intake and digestive system cancer risk in European and East Asian populations: a Mendelian randomization study.欧洲和东亚人群中绿茶摄入量与消化系统癌症风险之间的关联：一项孟德尔随机化研究
Eur J Nutr. 2024 Jun;63(4):1103-1111. doi: 10.1007/s00394-023-03312-8. Epub 2024 Feb 6.
2
Unexpected hydroxyl radical production in brewed tea under sunlight.阳光下冲泡茶中意外产生的羟基自由基。
PNAS Nexus. 2024 Jan 16;3(1):pgae015. doi: 10.1093/pnasnexus/pgae015. eCollection 2024 Jan.
3
Therapeutic potentialities of green tea (Camellia sinensis) in ischemic stroke: biochemical and molecular evidence.

本文引用的文献

1
Coffee or Tea? A prospective cohort study on the associations of coffee and tea intake with overall and cause-specific mortality in men versus women.咖啡还是茶？一项前瞻性队列研究探讨了男性和女性中咖啡和茶的摄入与总死亡率和死因特异性死亡率的关系。
Eur J Epidemiol. 2018 Feb;33(2):183-200. doi: 10.1007/s10654-018-0359-y. Epub 2018 Jan 27.
2
Green tea extracts for the prevention of metachronous colorectal polyps among patients who underwent endoscopic removal of colorectal adenomas: A randomized clinical trial.绿茶提取物预防内镜下结直肠腺瘤切除术后患者发生异时性结直肠息肉：一项随机临床试验。
Clin Nutr. 2018 Apr;37(2):452-458. doi: 10.1016/j.clnu.2017.01.014. Epub 2017 Jan 29.
3
绿茶（Camellia sinensis）在缺血性脑卒中的治疗潜力：生化和分子证据。
Metab Brain Dis. 2024 Feb;39(2):347-357. doi: 10.1007/s11011-023-01294-4. Epub 2023 Sep 18.
4
Review of Under-Recognized Adjunctive Therapies for Cancer.癌症未被充分认识的辅助治疗方法综述
Cancers (Basel). 2022 Sep 29;14(19):4780. doi: 10.3390/cancers14194780.
5
Green tea and cancer and cardiometabolic diseases: a review of the current epidemiological evidence.绿茶与癌症和心血管代谢疾病：当前流行病学证据的综述。
Eur J Clin Nutr. 2021 Jun;75(6):865-876. doi: 10.1038/s41430-020-00710-7. Epub 2020 Aug 20.
6
Coumaroyl Flavonol Glycosides and More in Marketed Green Teas: An Intrinsic Value beyond Much-Lauded Catechins.市售绿茶中的香豆酰基黄酮醇糖苷及其他成分：除了备受赞誉的儿茶素之外的内在价值。
Molecules. 2020 Apr 11;25(8):1765. doi: 10.3390/molecules25081765.
7
Green tea (Camellia sinensis) for the prevention of cancer.绿茶（茶树）预防癌症。
Cochrane Database Syst Rev. 2020 Mar 2;3(3):CD005004. doi: 10.1002/14651858.CD005004.pub3.
8
ERα36 is an effective target of epigallocatechin-3-gallate in hepatocellular carcinoma.雌激素受体α36是表没食子儿没食子酸酯在肝细胞癌中的有效靶点。
Int J Clin Exp Pathol. 2019 Sep 1;12(9):3222-3234. eCollection 2019.
9
Green tea consumption and mortality in Japanese men and women: a pooled analysis of eight population-based cohort studies in Japan.绿茶摄入与日本男女的死亡率：日本八项基于人群的队列研究的汇总分析。
Eur J Epidemiol. 2019 Oct;34(10):917-926. doi: 10.1007/s10654-019-00545-y. Epub 2019 Aug 7.
Association of green tea consumption with mortality from all-cause, cardiovascular disease and cancer in a Chinese cohort of 165,000 adult men.
在中国一个由16.5万名成年男性组成的队列中，绿茶消费与全因死亡率、心血管疾病死亡率和癌症死亡率之间的关联。
Eur J Epidemiol. 2016 Sep;31(9):853-65. doi: 10.1007/s10654-016-0173-3. Epub 2016 Jul 2.
4
Self-assembled micellar nanocomplexes comprising green tea catechin derivatives and protein drugs for cancer therapy.用于癌症治疗的由绿茶儿茶素衍生物和蛋白质药物组成的自组装胶束纳米复合物。
Nat Nanotechnol. 2014 Nov;9(11):907-912. doi: 10.1038/nnano.2014.208. Epub 2014 Oct 5.
5
Cancer prevention by tea: animal studies, molecular mechanisms and human relevance.茶对癌症的预防作用：动物研究、分子机制及与人类的相关性
Nat Rev Cancer. 2009 Jun;9(6):429-39. doi: 10.1038/nrc2641.
6
Chemoprevention of human prostate cancer by oral administration of green tea catechins in volunteers with high-grade prostate intraepithelial neoplasia: a preliminary report from a one-year proof-of-principle study.口服绿茶儿茶素对高级别前列腺上皮内瘤变志愿者进行前列腺癌化学预防：一项为期一年的原理验证研究的初步报告
Cancer Res. 2006 Jan 15;66(2):1234-40. doi: 10.1158/0008-5472.CAN-05-1145.
7
Reduced risk of esophageal cancer associated with green tea consumption.饮用绿茶与降低食管癌风险相关。
J Natl Cancer Inst. 1994 Jun 1;86(11):855-8. doi: 10.1093/jnci/86.11.855.